Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Thursday newspaper round-up: National Lottery, Mike Lynch, Morrisons

(Sharecast News) - The Czech billionaire whose company takes over running the UK national lottery from Thursday is still in business with the Kremlin-owned gas company Gazprom, nearly two years after promising regulators he would sever ties with Russia. The Gambling Commission awarded Allwyn the lucrative 10-year licence to run the lottery, estimated to be worth up to £100bn in sales, in March 2022. - Guardian Mike Lynch, the technology tycoon once lauded as the UK's answer to Bill Gates and now facing criminal fraud charges in the US, is suing the Serious Fraud Office. Lynch, who was extradited to the US last year to face trial over allegations he duped Hewlett-Packard into overpaying when it struck an $11bn (£8.6bn) deal to buy his software firm Autonomy in 2011, has filed a data protection claim against the SFO in the high court in London. - Guardian

A senior member of the Barclay family faces a petition from a leading private bank to declare him personally bankrupt, in the latest legal drama for the owners of The Telegraph. According to High Court documents, Alistair Barclay, 34, is alleged to be in default on £946,754 of borrowing from Investec, which only offers bank accounts to individuals with net wealth of more than £3m. - Telegraph

The new boss of Morrisons has started to invite shoppers to board meetings and has been holding customer "round tables" in stores as part of a plan to "re-energise and reshape" the troubled supermarkets chain. Rami Baitiéh, who joined as chief executive in November, admitted that Morrisons had "not been on peak form" since the pandemic and said he would reveal his new strategy for the business in March. - The Times

The competition regulator has started an investigation into a drugs company formerly run by the brother of Nasser Hussain, the ex-England cricket captain, over its supply of iron deficiency treatments to NHS patients. The Competition & Markets Authority said it was investigating suspected anti-competitive conduct by Vifor Pharma. - The Times

Share this article

Related Sharecast Articles

Sunday share tips: PPHE, Keystone Law
(Sharecast News) - The Financial Mail on Sunday's Midas column labelled shares of PPHE an "attractive long-term buy" citing their valuation.
Sunday newspaper round-up: Middle East, Aston Martin, Defence
(Sharecast News) - Britons must accept that their country was now involved in the Middle East conflict, Tobias Ellwood said. The former defence minister warned that "nobody was in full control" of the growing conflict as more and more countries were sucked in. Ellwood also said that Tehran's strike had taken the conflict into a "new dangerous territory". - Sunday Telegraph
Friday newspaper round-up: Everton, AstraZeneca, Amazon
(Sharecast News) - Everton has paid about £30m in interest charges to an opaque lender associated with a tax exile, corporate records suggest. The charges appear to have reached about £438,000 a week, according to the troubled Premier League club's most recent set of accounts, a figure more than three times the reported wages of the Everton and England goalkeeper Jordan Pickford. - Guardian
Thursday newspaper round-up: Border controls, McKinsey, KPMG
(Sharecast News) - New post-Brexit UK border controls coming into force later this month will cost British businesses £2bn and fuel higher inflation, according to a report warning that UK-EU trade will be damaged as a result. With less than a month before the introduction of new checks on animal and plant products from 30 April, the insurer Allianz Trade said the controls agreed under Boris Johnson's Brexit deal could add 10% to import costs over the first year. - Guardian

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.